Work

195eP Abridged (low cost) LORIS to predict response to immunotherapy in a LMIC

Year: 2025

Type: article

Abstract: Immuno-oncology (IO) therapy in India faces challenges of high cost and limited biomarker access. The Logistic Regression Immuno-Oncology Response Score (LORIS) integrates clinical and molecular predictors to guide IO benefit and may offer a practical solution in low-resource settings.

Source: Immuno-Oncology Technology

DOI: 10.1016/j.iotech.2025.101278

Authors: A. Syeda, P.S.T.R. Bhoomi Reddy, P.K.R. Kistampally, B.R. Teja, S.V.S. Attili

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,340

OpenAlex ID: W7117292747

FWCI:

Cites:

Cited by:

Related to: